HU 12 de Octubre

Madrid 28041

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Pulmonary Arterial Hypertension

Studies at this site

• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) — Stopped early